Experienced in Coronary Artery Bypass Graft (CABG)

Dr. William A. Gray

Internal Medicine | Hospital Medicine
130 Division St, 
Derby, CT 
Clinical Trials:Currently Recruiting for 2 Trials
Experienced in Coronary Artery Bypass Graft (CABG)
130 Division St, 
Derby, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Gray is a Hospital Medicine provider in Derby, Connecticut. Dr. Gray is rated as an Experienced provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Folliculitis, Stent Placement, and Angioplasty.

His clinical research consists of co-authoring 179 peer reviewed articles and participating in 15 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Coronary Artery Bypass Graft (CABG).

Specialties
Internal Medicine
Hospital Medicine
Licenses
Hospitalist in CT
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

130 Division St, Derby, CT 06418

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

A Multi-arm, Multi-Center, Non-Randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch
A Multi-arm, Multi-Center, Non-Randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch
Enrollment Status: Recruiting
Publish Date: July 03, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Study of Edwards Cardioband FIT Valve Repair System
Clinical Study of Edwards Cardioband FIT Valve Repair System
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Device, Other, Procedure
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study Of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW US)
Early Feasibility Study Of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW US)
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1 Delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter and a Novel Carotid Stent - the PERFORMANCE II Study
Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1 Delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter and a Novel Carotid Stent - the PERFORMANCE II Study
Enrollment Status: Active_not_recruiting
Publish Date: June 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Enrollment Status: Completed
Publish Date: December 20, 2023
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
Enrollment Status: Completed
Publish Date: March 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)
Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)
Enrollment Status: Unknown
Publish Date: February 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Multi-Center, Single-Arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects With De Novo Lesions of the Femoropopliteal Artery
A Prospective, Multi-Center, Single-Arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects With De Novo Lesions of the Femoropopliteal Artery
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Procedure, Device
Study Phase: Not Applicable
Natural Vascular Scaffold (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Natural Vascular Scaffold (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Enrollment Status: Completed
Publish Date: November 14, 2018
Intervention Type: Combination product
Study Phase: Phase 1
View 13 Less Clinical Trials

179 Total Publications

High-risk carotid plaque features may be more accurate predictors of ipsilateral ischemic stroke risk than the degree of carotid artery stenosis.
High-risk carotid plaque features may be more accurate predictors of ipsilateral ischemic stroke risk than the degree of carotid artery stenosis.
Journal: International angiology : a journal of the International Union of Angiology
Published: August 26, 2025
Similar Doctors
Distinguished in Coronary Artery Bypass Graft (CABG)
Dr. Frans J. Beerkens
Hospital Medicine
Distinguished in Coronary Artery Bypass Graft (CABG)
Dr. Frans J. Beerkens
Hospital Medicine
1468 Madison Ave, 
New York, NY 
 (58.7 miles away)
212-241-6500
Languages Spoken:
English
See accepted insurances

Frans Beerkens is a Hospital Medicine provider in New York, New York. Dr. Beerkens is rated as a Distinguished provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are Coronary Artery Bypass Graft (CABG) and Percutaneous Coronary Intervention (PCI).

Advanced in Coronary Artery Bypass Graft (CABG)
Dr. Yasar Sattar
Internal Medicine | Hospital Medicine
Advanced in Coronary Artery Bypass Graft (CABG)
Dr. Yasar Sattar
Internal Medicine | Hospital Medicine

Cogent Medical Care PC

12 N 7th Ave, 
Mount Vernon, NY 
 (48.8 miles away)
914-664-8000
Languages Spoken:
English
See accepted insurances

Yasar Sattar is a Hospital Medicine provider in Mount Vernon, New York. Dr. Sattar is rated as a Distinguished provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are End-Stage Renal Disease (ESRD), Spontaneous Coronary Artery Dissection (SCAD), Heart Failure with Preserved Ejection Fraction (HFpEF), Transcatheter Aortic Valve Replacement (TAVR), and Percutaneous Coronary Intervention (PCI).

Experienced in Coronary Artery Bypass Graft (CABG)
Dr. Sahil Khera
Hospital Medicine | Cardiology | Interventional Cardiology
Experienced in Coronary Artery Bypass Graft (CABG)
Dr. Sahil Khera
Hospital Medicine | Cardiology | Interventional Cardiology

Icahn School Of Medicine At Mount Sinai

1 Gustave L Levy Pl, 
New York, NY 
 (58.6 miles away)
212-731-7822
Experience:
10+ years
Languages Spoken:
English
See accepted insurances

Sahil Khera is a Hospital Medicine specialist and a Cardiologist in New York, New York. Dr. Khera has been practicing medicine for over 10 years and is rated as a Distinguished provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Cardiogenic Shock, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gray's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile